Alessandra Rustighi
Area Science Park
Trieste, Italy
Trieste, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Prolyl-isomerase Pin1 drives platinum resistance by regulating Notch3 stability and function in ovarian cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: October 08, 2025
ALCAM-mediated cDC1 CD8 T cells interactions are suppressed in advanced lung tumors.
Journal: Oncoimmunology
Published: June 18, 2024
p53 inactivation drives breast cancer metastasis to the brain through SCD1 upregulation and increased fatty acid metabolism.
Journal: Nature genetics
Published: February 07, 2024
Author Correction: Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growth.
Journal: Nature communications
Published: November 06, 2023
EMID2 is a novel biotherapeutic for aggressive cancers identified by in vivo screening.
Journal: Journal of experimental & clinical cancer research : CR
Published: September 30, 2023
Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growth.
Journal: Nature communications
Published: August 04, 2023
The prolyl-isomerase PIN1 is essential for nuclear Lamin-B structure and function and protects heterochromatin under mechanical stress.
Journal: Cell reports
Published: February 16, 2021
Oncogenic Hijacking of the PIN1 Signaling Network.
Journal: Frontiers in oncology
Published: December 07, 2018
Dynamic landscape and regulation of RNA editing in mammals.
Journal: Nature
Published: September 23, 2016
A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action.
Journal: Nature communications
Published: August 25, 2016
PIN1 in breast development and cancer: a clinical perspective.
Journal: Cell death and differentiation
Published: July 07, 2016
Last Updated: 09/26/2026